Vaklavas C, Roberts BS, Varley KE, Lin NU, et al. TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole
with or without bevacizumab in postmenopausal women with newly diagnosed stage
2/3 hormone receptor-positive and HER2-negative breast cancer. Breast Cancer Res 2020;22:22.
PMID: 32070401